ProCE Banner Activity

An Ounce of Prevention: A Canadian Perspective on DoxyPEP and DoxyPrEP

Clinical Thought

Learn how data from AIDS 2024 on doxyPEP and doxyPrEP and new insights into the potential for antibiotic resistance will shape the future of STI prevention in Canada.

Released: August 16, 2024

Expiration: August 15, 2025

Share

Faculty

Darrell H S Tan

Darrell H S Tan, MD, FRCPC, PhD

Clinician-Scientist
Division of Infectious Diseases
St Michael's Hospital
Toronto, Ontario, Canada

Provided by

Provided by Clinical Care Options, LLC in partnership with the International AIDS Society

ProCE Banner

Supporters

Supported by educational grants from Gilead Sciences, Inc. and ViiV Healthcare.

Gilead Sciences, Inc.

ViiV Healthcare

Partners

IAS

ProCE Banner

Disclosure

Primary Author

Darrell H S Tan, MD, FRCPC, PhD

Clinician-Scientist
Division of Infectious Diseases
St Michael's Hospital
Toronto, Ontario, Canada

Darrell H. S. Tan, MD, FRCPC, PhD: researcher: Gilead, GlaxoSmithKline.

Presenter

Angela Davies, MD

Assistant Professor of Medicine
UC Davis Cancer Center
Sacramento, CA